Radio and PodcastRadio and PodcastLive Radio & Podcasts
HOPA 2026 Recap artwork
Science & Medicine

HOPA 2026 Recap

OncoPharm by OncoPharmPod

Apr 2, 202600:13:36Science & Medicine

Recapping what I learned at HOPA 2026: -Beyond steroids for irAs -IT chemo beyond methotrexate and cytarabine -Pre-emptive CMV management in patients receiving certain bispecifics -semaglutide-alectinib drug interaction...

About This Episode

HOPA 2026 Recap is an episode from OncoPharm by OncoPharmPod. Recapping what I learned at HOPA 2026: -Beyond steroids for irAs -IT chemo beyond methotrexate and cytarabine -Pre-emptive CMV management in patients receiving certain bispecific...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 2, 2026, 00:13:36 long, audio available.

Related Episodes

Continue listening to more episodes from OncoPharm.

IMHOTEP, PJP, and more

May 14, 2026 - 00:09:59

This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pC...

Vepdegestrant

May 7, 2026 - 00:11:35

The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated br...

Targets Trop 2

Apr 30, 2026 - 00:12:41

This is our 1st in a series of podcasts/videos to role out once or twice a year on therapeutic targets in...

Promising Pancreatic Cancer Data

Apr 23, 2026 - 00:13:56

This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has...

ICI-Induced T1DM

Apr 16, 2026 - 00:13:24

Bibliography: 1.. 2019 Systematic Review of Published Cases: 2. Mass General Data & Publication: 3. Japan...

Relacorilant

Apr 9, 2026 - 00:15:13

Discussing the new nab-paclitaxel adjunctive medication, relacorilant, for ovarian cancer. As a glucoCORt...

Nivo-AVD Approval

Mar 24, 2026 - 00:09:32

Nivolumab-AVD is finally approved for Hodgkin Lymphoma, and primary G-CSF prophylaxis is recommended (?)...

Tazemetostat Withdrawl and RECITE

Mar 19, 2026 - 00:14:47

Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplo...

Questions About This Episode

What is HOPA 2026 Recap about?

Recapping what I learned at HOPA 2026: -Beyond steroids for irAs -IT chemo beyond methotrexate and cytarabine -Pre-emptive CMV management in patients receiving certain bispecifics -semaglutide-alectinib drug interaction -Safety (n = ~40) of MMR vaccine in patients post-Auto transplant on maintenance daratumumab Check out the Oncology Insights Newsletter:

Where can I listen to HOPA 2026 Recap?

You can listen to HOPA 2026 Recap online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is HOPA 2026 Recap from?

HOPA 2026 Recap is an episode from OncoPharm by OncoPharmPod.

How long is this episode?

This episode is 00:13:36 long.

When was this episode published?

This episode was published on Apr 2, 2026.

Can I save HOPA 2026 Recap for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from OncoPharm?

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.